News
Important Only
US Stock Futures Advance Monday as Market Focuses on Middle East Situation
TradingKey - Major U.S. equity index futures traded higher on Monday as oil prices continued to climb. As of 8:00 AM ET, S&P 500 futures rose 34 points, or 0.53%; Nasdaq 100 futures gained 0.50%; and Dow Jones futures were up 254 points.
TradingKey
46 minutes ago
South Korea's AI chip startup Rebellions raises $400 million in latest funding round
SEOUL, March 30 (Reuters) - South Korean artificial intelligence chip startup Rebellions said on Monday it had raised $400 million in its latest funding round, valuing the company at about $2.34 billion as it accelerates expansion into the U.S.The round, led by Mirae Asset Financial Group and the Ko...Reuters
9 minutes ago
ROI-Bond blues hit Big Tech at the worst time: McGeever
By Jamie McGeever ORLANDO, Florida, March 30 (Reuters) - No borrower will escape the surge in market-based interest rates unleashed by the Middle East war and resulting energy supply shock. But for U.S. tech firms planning to spend over $600 billion this year in the artificial intelligence arms r...Reuters
9 minutes ago
Seagate Technology gains; JPM starts with 'overweight' rating
Shares of data storage firm Seagate Technology STX.O rise 2.6% to $390.00 premarketJ.P. Morgan begins STX coverage with "overweight" rating and a price target of $525, implying ~38% upside to the stock's last closeJPM says the hard disk drive industry and STX are positioned to see robust...Reuters
9 minutes ago
US food giant Sysco strikes $29 billion deal for catering supplier Restaurant Depot
Deal to be financed with $21 billion in new and hybrid debt, alongside $1 billion on handShares of Sysco down about 8% premarketRestaurant Depot shareholders to own about 16% of Sysco following dealSysco pauses share repurchase program amid acquisitionBy Neil J Kanatt March 30 (Reuters) - Sysco S...Reuters
12 minutes ago
Alaska Air falls on wider Q1 loss forecast
Shares of Alaska Air ALK.N fall nearly 1% to about $36 premarketCo forecast a Q1 adjusted loss of $2.00 to $1.50 per share, compared with analysts' estimate of a 99-cent loss - data compiled by LSEGSays demand strength that emerged in late 2025 and accelerated early this year has recently faced ...Reuters
18 minutes ago
Instacart rises after Jefferies upgrades to 'buy'
Shares of online grocery delivery firm Instacart CART.O, formally known as Maplebear, up 2% at $36.11 premarketJefferies upgrades to "buy" from "hold", raises PT from $38 to $45, a 26% upside to the stock's last close Double-digit gross transaction value growth - a key metric tha...Reuters
19 minutes ago
Why April Could Be a Turning Point for Tesla Stock
Key PointsA key decision from a European authority in April could raise awareness of the intrinsic value of Tesla's full self-driving technology. The company is likely to report year-over-year growth in vehicle deliveries in April. These 10 stocks could mint the next wave of millionaires › Given the...The Motley Fool
19 minutes ago
Want $7,500 in Monthly Retirement Income? Here's the Nest Egg You Need.
Key PointsOne popular strategy says you should save 25 times your estimated annual retirement expenses.You won't have to pay for all of your retirement expenses on your own.This strategy is designed to work with the 4% rule, which may not be right for you.The $23,760 Social Security bonus most retir...The Motley Fool
19 minutes ago
Biogen rises as FDA clears higher-dose Spinraza for muscle disease
Shares of drugmaker Biogen BIIB.O rise 1.75% to $187.06 premarketCo says the FDA approved a higher-dose version of Spinraza to treat spinal muscular atrophy, a rare genetic disease that causes severe muscle weakness and can be fatalThe new dosing can be used in both new patients and those already on...Reuters
20 minutes ago
Ultragenyx rises after FDA clears human trial for rare muscle disease drug
Shares of drugmaker Ultragenyx Pharmaceutical RARE.O rise 2% to $19.76 premarketCo says U.S. FDA cleared its application to start human testing of UX016 for GNE myopathy, a rare inherited muscle disease that causes worsening muscle weakness and disabilityThere are no approved treatments for the cond...Reuters
22 minutes ago
Viridian plunges after thyroid eye disease drug falls short of expectations
Shares of drug developer Viridian Therapeutics VRDN.O fall 37.60% to %17.09 premarket Co says its drug, elegrobart, met the main goal in a late-stage study in patients with active thyroid eye disease, an autoimmune condition that affects the tissues around the eyesPatients receiving elegrobart every...Reuters
27 minutes ago
US STOCKS-Wall St set for higher open after recent selloff, Mideast conflict widens
Futures up: Dow 0.66%, S&P 500 0.68%, Nasdaq 0.66%Sysco falls after $29 bln Jetro Restaurant Depot buyout dealMorgan Stanley downgrades global equities to "equal weight"Comments from Fed's Jerome Powell, John Williams awaited By Purvi Agarwal and Twesha Dikshit March 30 (Reuters) ...Reuters
28 minutes ago
Nasdaq To Update Nasdaq-100 Index Methodology
March 30 (Reuters) - Nasdaq Inc NDAQ.O:NASDAQ: PROPOSAL FOR “FAST ENTRY” FOR NEW NASDAQ LISTED LARGE COMPANIES WILL BE ADOPTED WITH SOME MODIFICATIONSNASDAQ: PROPOSAL FOR CALCULATION OF MARKET CAP FOR ELIGIBILITY PURPOSES WILL BE ADOPTED AS PROPOSEDNASDAQ: PROPOSAL FOR REPLACEMENT OF “10 BASIS POINT...Reuters
32 minutes ago
4 Estate Planning Moves to Make Before 2026 Ends
Key PointsBeneficiaries selected through your account administrators override what's in your will.You can gift up to a certain amount each year without it triggering gift taxes.Converting a traditional IRA to a Roth IRA could save you money in taxes the long run.The $23,760 Social Security bonus mos...The Motley Fool
34 minutes ago
Expedia rises after Jefferies upgrades to 'buy'
Shares of online travel company Expedia Group EXPE.O rise 2.5% to $231.50 premarketJefferies upgrades EXPE's rating to "buy" from "hold"; raises price target to $300 from $240 New PT represents a 32.9% upside to stock's last closeBrokerage says EXPE's continued delivery o...Reuters
40 minutes ago
Altria's Oral Nicotine Pouch Product Is Going Nationwide. Is the Stock a Buy in 2026?
Key PointsTobacco giant Altria continues to evolve as its cigarette business moves toward its inevitable end.Nicotine pouches are a clever alternative vice, and the company is now expanding their availability.There may not be a great deal of net growth opportunity to this initiative. That doesn’t ch...The Motley Fool
44 minutes ago
73% of Institutional Investors Are Bullish About This Set of Catalysts for XRP and Solana
Key PointsA new regulatory framework and a potential upcoming market structure bill could both be big catalysts for crypto.Institutional investors are planning to buy more crypto this year as a result.XRP and Solana will probably benefit significantly.10 stocks we like better than XRP › Big money te...The Motley Fool
49 minutes ago
Vertical Aerospace bounces on $800 mln financing
US-listed shares of air-taxi maker Vertical Aerospace EVTL.N up 10.7% at $2.28 premarket after it enters agreement for up to $800 mln comprehensive financing packageEVTL shares had fallen prior six sessions, shedding ~44% to record low close of $2.06 on FriUK-based firm early Mon says Mudrick Capita...Reuters
49 minutes ago
Novavax rises after naming internal medicine specialist as R&D head
Shares of vaccine maker Novavax NVAX.O rise 1.5% to $8.58 premarketCo appoints Robert Walker as executive vice president and head of research and development, effective immediatelyWalker, previously the firm's chief medical officer, replaces Ruxandra Draghia-Akli, who has left the companyCo says...Reuters
51 minutes ago
